Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

astrazeneca_plaque

AstraZeneca admits cancer data for acquired drug was fabricated

October 16, 2017
Research and Development, Sales and Marketing Acerta, AstraZeneca, acalabrutinib

AstraZeneca has revealed that early-stage data concerning the efficacy of its acquired drug acalabrutinib in the treatment of blood cancers …

News
astrazeneca-sign

AstraZeneca’s Tagrisso secures Breakthrough Therapy Designation in first-line NSCLC

October 9, 2017
Sales and Marketing AstraZeneca, Cancer, NSCLC, immunotherapy, lung cancer

AstraZeneca has announced that its targeted therapy, Tagrisso (osimertinib), has been awarded Breakthrough Therapy Designation by the FDA for the …

News
astrazeneca_logo_building

AstraZeneca Chairman wants three-year Brexit transition period

October 3, 2017
Manufacturing and Production, Medical Communications AstraZeneca, biotech, brexit, drugs, pharma, pharmaceutical

The Chairman of AstraZeneca, Leif Johansson, revealed in no uncertain terms that his company would like there to be a …

News
online_version

New CMO hops onto Bicycle Therapeutics

September 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …

Appointment
astrazeneca_logo_building

AstraZeneca’s Forxiga displays potential in type 1 diabetes

September 14, 2017
Research and Development AstraZeneca, Forxiga, biotech, drugs, farxiga, pharma, pharmaceutical

Forxiga is AstraZeneca’s treatment for those living with type 2 diabetes but the results from a new trial have found …

News
astrazeneca_plaque

AstraZeneca’s Tagrisso beats standard of care in halting NSCLC

September 11, 2017
Research and Development, Sales and Marketing AstraZeneca, ESMO, NSCLC, Tagrisso, non-small cell cell cancer, pharma, pharmaceutical

AstraZeneca has revealed new data at the European Society of Medical Oncology (ESMO) on the efficacy of Tagrisso (osimertinib) in …

News
shutterstock_232245868

Amgen and AstraZeneca’s experimental drug cuts asthma exacerbations by up to 71%

September 7, 2017
Research and Development Amgen, AstraZeneca, MedImmune, asthma, pharma, pharmaceutical, tezepelumab

An anti-TSLP monoclonal antibody jointly developed by Amgen and AstraZeneca’s global biologics and research division, MedImmune, has met its primary …

News
astrazeneca-sign

AstraZeneca’s Brilinta protects against adverse cardiovascular events for up to 5 years, new data reveals

September 7, 2017
Research and Development AstraZeneca, Brilinta, cardiovascular, heart attack, pharma, pharmaceutical, ticagrelor, trial

AstraZeneca has revealed new data supporting the long-term use and efficacy of its cardiovascular drug Brilinta (ticagrelor), showing that the …

News
astrazeneca_building_white

NICE rejects AstraZeneca’s breast cancer drug Faslodex

September 1, 2017
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

News
astrazeneca_logo_building

AstraZeneca unloads another drug for $400m

August 29, 2017
Research and Development, Sales and Marketing AstraZeneca, Takeda, biotech, drugs, pharma, pharmaceutical

AstraZeneca has had to do a serious re-think of its portfolio post-Mystic failure and it has made another move to …

News
astrazeneca-sign

AstraZeneca invests “tens of millions” into Cheshire, UK manufacturing site

August 29, 2017
Manufacturing and Production, Research and Development AZ, AstraZeneca, Cheshire, Chesire, UK, life sciences, pharma, pharmaceuticals

AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …

News
astrazeneca_building_white

Extended use of AstraZeneca’s Brilinta reduces cardiovascular death risk

August 24, 2017
Research and Development AstraZeneca, Brilinta, cardiovascular, heart attack, life sciences, pharma, pharmaceutical

New data for AstraZeneca’s blood thinner Brilinta (ticagrelor) has shown that extended use of the drug can cut the risk …

News
astrazeneca-sign

AstraZeneca strikes mRNA-based partnership in respiratory disease

August 22, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Ethris, MedImmune, mrna, pharma, pharmaceuticals

AstraZeneca and MedImmune, the company’s biologics research arm, have forged a five year research partnership with mRNA-based pulmonary disease specialist …

News
astrazeneca_logo_building

AZ and MSD secure three bits of good news on key drug

August 18, 2017
Medical Communications, Sales and Marketing AstraZeneca, MSD, biotech, drugs, pharma, pharmaceutical

It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly …

News
astrazeneca_logo_building

AstraZeneca’s Priority Review good news provides reprieve

August 2, 2017
Sales and Marketing AstraZeneca, FDA, biotech, drugs, pharma, pharmaceutical

If there was a company that needed a series of good news stories this week, it was AstraZeneca. The blow …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026